CTMX vs EIX
CytomX Therapeutics Inc (CTMX) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
CytomX Therapeutics Inc (CTMX) is a biotechnology company listed on US.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported CTMX revenue for 2024-12-31 was $138.1M. Net income was $31.9M. Revenue was up 36.4% from 2023-12-31 to 2024-12-31. CTMX currently screens at market cap $653.1M.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
CTMX currently screens at market cap $653.1M. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the CTMX and EIX stock pages for the full models.
Not investment advice.